aSynPEP-DB: a database of biogenic peptides for inhibiting α-synuclein aggregation

Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, yet effective treatments able to stop or delay disease progression remain elusive. The aggregation of a presynaptic protein, α-synuclein (aSyn), is the primary neurological hallmark of PD and, thus, a promising target...

Descripción completa

Detalles Bibliográficos
Autores principales: Pintado-Grima, Carlos, Bárcenas, Oriol, Iglesias, Valentín, Santos, Jaime, Manglano-Artuñedo, Zoe, Pallarès, Irantzu, Burdukiewicz, Michał, Ventura, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681447/
https://www.ncbi.nlm.nih.gov/pubmed/38011719
http://dx.doi.org/10.1093/database/baad084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681447/
https://www.ncbi.nlm.nih.gov/pubmed/38011719
http://dx.doi.org/10.1093/database/baad084

Ejemplares similares